Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts Browse Latest Filings
Sign up to stay up to date with the stocks you care about
Add AVACTA GROUP PLC to Feed

AVACTA GROUP PLC

avacta.com

About AVACTA GROUP PLC

Avacta Group plc is a life sciences company with a focus on improving healthcare and well-being through innovative oncology drugs and diagnostics. The company operates through two divisions, Diagnostics and Therapeutics. The Therapeutics Division is developing a pipeline of novel Affimer® immunotherapies and pre|CISION™ tumour targeted chemotherapies to address challenges in cancer treatment. The Diagnostics Division supplies in-vitro diagnostic solutions, growing rapidly through an M&A strategy to become a global scale IVD business offering market-leading healthcare solutions. The company's research and development center uses the proprietary Affimer® platform to differentiate immunodiagnostic products, enhancing their performance. ...

Latest news & discussion for AVACTA GROUP PLC:

1
1
2
1
3
1
4
1
5
1
6
1
7
1
8
1
9
1
10
1
11
1
12
1
13
1
14
1
15
1
16
1
17
1
18
1
19
1
20
1
21
1
22
1
23
1
24
1
25
1